Abbott Laboratories buy Royal Bank of Canada
Start price
25.01.24
/
50%
€102.54
Target price
25.01.25
€118.09
Performance (%)
-5.08%
Price
29.07.24
€96.81
Summary
This prediction is currently active. With a performance of -5.08%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. Dividends of €0.52 are taken into consideration when calculating the performance. This prediction currently runs until 25.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 1.723% | 1.723% |
iShares Core DAX® | -0.598% | 0.645% |
iShares Nasdaq 100 | -3.290% | -4.193% |
iShares Nikkei 225® | -0.796% | -0.582% |
iShares S&P 500 | -1.164% | -0.857% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $128.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€94.80
04.06.24
04.06.24
€114.98
04.06.25
04.06.25
2.12%
29.07.24
29.07.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€98.67
19.04.24
19.04.24
€117.41
19.04.25
19.04.25
-1.89%
29.07.24
29.07.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
-6.56%
29.07.24
29.07.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
-5.00%
29.07.24
29.07.24